The team behind Apple’s Face ID is developing tiny robots to deliver drugs into the brain, controlled by magnetic propulsion, to target hard to treat diseases.
Los Angeles-based Bionaut Labs raised $43.2mn in a second round of financing led by Khosla Ventures to fund the first clinical trials to try to prove that the robots are safe and effective.
Seven new investors, including Israel’s Deep Insight and Canada’s Sixty Degree Capital, joined the round.
您已阅读14%（455字），剩余86%（2784字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。